A trial to evaluate the safety, immunogenicity, and clinical activity of a helper peptide vaccine plus combination of BRAF inhibition and MEK inhibition (Mel61)

IRB/UVA Tracking #
17700
Contact First Name

Adela Mahmutovic

Contact Email
Phase
I/II
Primary purpose
Treatment
Cancer PI
Elizabeth M Gaughan
Status
OPEN TO ACCRUAL